DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Aeberli D, Oertle S, Mauron H. et al.
Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders.
Swiss Med Wkly 2002; 132: 414-422
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.